With a 5-year, $1 million K23 grant from the National Institutes of Health (NIH), Swarup Swaminathan, M.D., Assistant Professor of Clinical Ophthalmology at the Miller School of Medicine and Miami CTSI Pilot Awardee, is working on techniques to identify glaucoma in patients sooner.
The Miami Clinical and Translational Science Institute (CTSI) is pleased to announce that it is once again offering personalized, one-on-one grant writing consultations to University of Miami faculty researchers.
An analysis of data from the All of Us Research Program led by Miami CTSI MPI and Co-Director Olveen Carrasquillo, M.D., M.P.H., and mentee Raul Montanez-Valverde, M.D., suggests that Latinos don't face less risk for cardiovascular disease — calling into question the Latino epidemiological paradox.
Preliminary results from the ACTIV-1 Immune Modulator clinical trial show that immune modulator drugs, infliximab and abatacept, substantially improved clinical status and reduced deaths in adults hospitalized with COVID-19.
Recovery from surgery can be challenging, even for patients in the best of health. Elizabeth Mahanna Gabrielli, M.D., an Associate Professor of Anesthesiology and researcher at the University of Miami Miller School of Medicine, wants to improve quality of life for patients undergoing surgery by preventing a common side effect, delirium.
The Miami CTSI presented four posters at the Translational Science 2022 Meeting in Chicago showcasing its achievements and impact in translational research workforce education and training.
Artificial intelligence (AI) is changing the way ophthalmic conditions are diagnosed. Miami CTSI pilot awardee Delia Cabrera DeBuc, Ph.D., wants to make sure that AI is capturing the whole picture for every patient.
Through mentorship and collaboration, Miami CTSI KL2 Scholar Katlyn Meier, Ph.D., is working to better understand the relationship that metals like iron and copper have in influencing Huntington’s disease.
As a pediatric critical care attending, Jennifer Munoz-Pareja, M.D., had always been interested in neuroscience research. When she was hospitalized with a traumatic brain injury (TBI) in 2012, she witnessed firsthand how patients, families, and healthcare providers are largely working in the dark when it comes to caring for patients with TBI. “I thought, ‘Wow. We really don’t have treatments. Nothing really works for these patients,’” she says.
Eric A. Mellon, M.D., Ph.D., associate professor of radiation oncology and biomedical engineering, has been awarded a $5 million seven-year grant from the National Cancer Institute (NCI) to study how advanced imaging during treatment may be used to improve radiation therapy for patients with glioblastoma, a deadly brain tumor. Dr. Mellon’s pilot award from the Miami CTSI in 2019 contributed scientific data to this latest award.